美股A股
StockGist
Back
10-K/A2026-04-29· grok-4-1-fast-non-reasoning

XBIT · XBiotech Inc.

0001171843-26-002814

SEC filing

Summary

This 10-K/A amendment provides no new financial data but reveals leadership transition and elevated executive compensation amid persistent net losses and shareholder value erosion.